Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers
Authors:
- Guoli HuangGHGuoli Huang
- Yang ZhouYZYang Zhou
- Hao WangHWHao Wang
- Xiucai MaXMXiucai Ma
Open Access
- 17 September 2026
- journal article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 61
Abstract
No abstract availableFunding Information
- Lanzhou Science and Technology Bureau (2023-4-58)
- Natural Science Foundation of Gansu Province (24JRRA1059)
- Health Commission of Gansu Province (GSWSKY2021\u2013013)
This publication has 70 references indexed in Scilit:
- Advances in liquid biopsy for bone and soft-tissue sarcomasInternational Journal of Clinical Oncology, 2025
- Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic reviewArchives of orthopaedic and trauma surgery, 2025
- Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study GroupCancer Medicine, 2023
- Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a modelSkeletal Radiology, 2023
- Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an updatePediatric Radiology, 2021
- MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter studyEuropean Radiology, 2021
- A systematic review of radiomics in osteosarcoma: utilizing radiomics quality score as a tool promoting clinical translationEuropean Radiology, 2020
- A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumorsCancer Medicine, 2020
- Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsiesPediatric Blood & Cancer, 2019
- Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experienceCancer, 2013